Antioxidant Enzymes and Fatty Acid Status in Erythrocytes of Down Syndrome Patients (Enzymes and Protein Markers) Antioxidant Enzymes and Fatty Acid Status in Erythrocytes of Down Syndrome Patients (Enzymes and Protein Markers)

Antioxidant Enzymes and Fatty Acid Status in Erythrocytes of Down Syndrome Patients (Enzymes and Protein Markers‪)‬

Clinical Chemistry 1998, May, 44, 5

    • CHF 3.00
    • CHF 3.00

Publisher Description

Reactive oxygen (RO) (4) species are substances that are released during oxidative metabolism. RO species include the superoxide anion (OZ-), hydrogen peroxide ([H.sub.2][O.sub.2]), and the hydroxyl radical (O[H.sup.*]) (1). The reactions of RO species with macromolecules can lead to DNA mutations, changes in the structure and function of proteins, and peroxidative damage of cell-membrane lipids (2). There is a primary defense system against oxidative stress, mediated by sequential enzymatic reactions. In the first step of the process, CuZn-superoxide dismutase (SOD1) catalyzes the dismutation of [O.sub.2.sup.-] to [H.sub.2][0.sub.2]. Glutathione peroxidase (GPx) and catalase (CAT) then independently convert [H.sub.2][0.sub.2] to water (3). Any increase in SOD1 catalytic activity, therefore, produces an excess of [H.sub.2][0.sub.2] that must be efficiently neutralized by either GPx or CAT. Otherwise, [H.sub.2][0.sub.2] reacts with [O.sub.2.sup.-], producing O[H.sup.*], which is one of the most active RO species. Thus the activity of the first-step (SOD1) and second-step (GPx, CAT) antioxidant enzymes must be balanced to prevent cell damage. In addition to the antioxidant enzymatic system, some micronutrients act as nonenzymatic antioxidants by scavenging RO species. [alpha]-Tocopherol (vitamin E) is the most important nonenzymatic antioxidant system in the organism (4). Its action occurs mostly in cell membranes by protecting them from lipoperoxidation. An imbalance between the oxidative stress and the cell antioxidant system may produce cell membrane damage by oxidation of its lipid matrix, particularly polyunsaturated fatty acids (PUFAs), which are the main substrates for lipid peroxidation (5).

GENRE
Science & Nature
RELEASED
1998
1 May
LANGUAGE
EN
English
LENGTH
20
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
203.8
KB

More Books by Clinical Chemistry

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report) The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report)
2009
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs) Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs) Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials) Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005